Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Texas Instruments Incorporated, 3 years.
Texas Instruments Incorporated
Director
Samsara Inc.
Director
Medline Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Samsara Inc. July 22, 202697.2%
-
Medline Inc. June 11, 202699.6%
-
Texas Instruments Incorporated April 16, 202688.0%
-
Samsara Inc. July 29, 202598.5%
-
Texas Instruments Incorporated April 17, 202594.4%
-
Samsara Inc. July 10, 2024100.0%
-
Texas Instruments Incorporated April 25, 202495.1%
-
Texas Instruments Incorporated April 27, 202398.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | Samsara Inc. | Grant or award | +7,801 | — | — |
| Jun 11, 2026 | Medline Inc. | Grant or award | +5,387 | — | — |
| Apr 24, 2026 | Texas Instruments Incorporated | Option exercise | +4,306 | $110.15 | $474,306 |
| Apr 24, 2026 | Texas Instruments Incorporated | Open-market sale | −4,306 | $274.25 | $1,180,921 |
| Jan 29, 2026 | Texas Instruments Incorporated | Grant or award | +525 | — | — |
| Dec 16, 2025 | Medline Inc. | Grant or award | +10,345 | — | — |
| Jul 29, 2025 | Samsara Inc. | Grant or award | +6,371 | — | — |
| Jan 27, 2025 | Texas Instruments Incorporated | Grant or award | +614 | — | — |
| Sep 4, 2024 | Samsara Inc. | Grant or award | +1,293 | — | — |
| Jul 10, 2024 | Samsara Inc. | Grant or award | +5,685 | — | — |
| Jan 25, 2024 | Texas Instruments Incorporated | Grant or award | +686 | — | — |
| Aug 4, 2023 | Samsara Inc. | Grant or award | +15,468 | — | — |
| Jan 26, 2023 | Texas Instruments Incorporated | Grant or award | +574 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.